Q2 2025 Earnings Call Transcript August 11, 2025 Humacyte, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, ...

In a modest Primary Health Centre tucked deep in Yobe State, Fatimah cradled her newborn with a mix of relief and disbelief.

Vexev announced today that it completed enrollment in a clinical trial evaluating its semi-autonomous ultrasound scanning technology.

TJ Rueda, a Coahoma native, has had troubling health issues the past several years. In 2018, Rueda was diagnosed with Vasculitis, a disorder that causes ...

The Vexev and U.S. Renal Care teams successfully completed enrollment in the CANSCAN trial. The study is evaluating the use of semi-autonomous ultrasound scanning with the VxWave Ultrasound Imaging ...

Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, today ...

Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for AV Fistula Mapping in Dialysis ClinicsCANSCAN study enrolled 120 patients with ...

Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, today ...